{
  "id": "RL34635",
  "type": "CRS Report",
  "typeId": "REPORTS",
  "number": "RL34635",
  "active": true,
  "source": "EveryCRSReport.com, University of North Texas Libraries Government Documents Department",
  "versions": [
    {
      "source": "EveryCRSReport.com",
      "id": 419888,
      "date": "2012-12-13",
      "retrieved": "2016-04-06T21:33:45.779275",
      "title": "The Controlled Substances Act: Regulatory Requirements",
      "summary": "This report highlights certain non-criminal regulatory requirements of the Controlled Substances Act (CSA). The CSA and its implementing regulations establish a framework through which the federal government regulates the use of controlled substances for legitimate medical, scientific, research, and industrial purposes, and prevents these substances from being diverted for illegal purposes. The CSA assigns various plants, drugs, and chemicals (such as narcotics, stimulants, depressants, hallucinogens, and anabolic steroids) to one of five schedules based on the substance\u2019s medical use, potential for abuse, and safety or dependence liability. Schedule I contains substances that have no currently accepted medical use and cannot safely be made available to the public under a prescription, while Schedules II, III, IV, and V include substances that have recognized medical uses and may be manufactured, distributed, and used in accordance with the CSA. The order of the schedules reflects substances that are progressively less dangerous and addictive. To restrict access to chemicals used in the illicit manufacture of certain controlled substances, the CSA also regulates 40 \u201clisted chemicals.\u201d Furthermore, the CSA regulates controlled substance \u201canalogues,\u201d which are substances that are not controlled but are structurally or pharmacologically similar to substances found in Schedule I or II and have no accepted medical use.\nUnless specifically exempted by the CSA, any person who handles controlled substances or listed chemicals (such as drug manufacturers, wholesale distributors, doctors, hospitals, pharmacies, and scientific researchers) must register with the Drug Enforcement Administration (DEA) in the U.S. Department of Justice, which administers and enforces the CSA. Registrants must keep accurate and complete records of all transactions involving controlled substances, maintain detailed inventories of the substances in their possession, and periodically file reports with the DEA, as well as ensure that controlled substances are securely stored and safeguarded in accordance with DEA regulations.\nBetween 10%-11% of all drug prescriptions written in the United States are for pharmaceutical controlled substances. Only licensed medical practitioners (who are registered with the DEA) are authorized to prescribe controlled substances listed in Schedules II-V to patients; such prescriptions may only be issued by a practitioner who is \u201cacting in the usual course of his professional practice,\u201d and for a \u201clegitimate medical purpose.\u201d The CSA authorizes the DEA Administrator to suspend or revoke a physician\u2019s prescription privileges upon a finding that he has \u201ccommitted such acts as would render his registration ... inconsistent with the public interest.\u201d\nWhile the CSA provides criminal sanctions for illicit possession, manufacture, or distribution of controlled substances, the statute also contains a few noteworthy penalty provisions that are specifically applicable to persons who are authorized by the DEA to handle controlled substances lawfully. The CSA sets forth certain offenses involving listed chemicals and DEA registration and other prohibited acts relating to registrants who manufacture, distribute, and dispense controlled substances.",
      "type": "CRS Report",
      "typeId": "REPORTS",
      "active": true,
      "formats": [
        {
          "format": "HTML",
          "encoding": "utf-8",
          "url": "http://www.crs.gov/Reports/RL34635",
          "sha1": "7fe69cc1bdbb2b126ce2db6531bd57c7797c4455",
          "filename": "files/20121213_RL34635_7fe69cc1bdbb2b126ce2db6531bd57c7797c4455.html",
          "images": null
        },
        {
          "format": "PDF",
          "encoding": null,
          "url": "http://www.crs.gov/Reports/pdf/RL34635",
          "sha1": "ee842e18f77c86ba80a028e2b641d26be9a12d53",
          "filename": "files/20121213_RL34635_ee842e18f77c86ba80a028e2b641d26be9a12d53.pdf",
          "images": null
        }
      ],
      "topics": []
    },
    {
      "source": "University of North Texas Libraries Government Documents Department",
      "sourceLink": "https://digital.library.unt.edu/ark:/67531/metadc805682/",
      "id": "RL34635_2008Oct28",
      "date": "2008-10-28",
      "retrieved": "2016-03-19T13:57:26",
      "title": "The Controlled Substances Act: Regulatory Requirements",
      "summary": null,
      "type": "CRS Report",
      "typeId": "REPORT",
      "active": false,
      "formats": [
        {
          "format": "PDF",
          "filename": "files/20081028_RL34635_da96c178fbc11c2e9ad05884a8f4dfd0539f96d0.pdf"
        },
        {
          "format": "HTML",
          "filename": "files/20081028_RL34635_da96c178fbc11c2e9ad05884a8f4dfd0539f96d0.html"
        }
      ],
      "topics": []
    }
  ],
  "topics": []
}